Anders Husby

1.7k total citations · 2 hit papers
18 papers, 609 citations indexed

About

Anders Husby is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Anders Husby has authored 18 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Anders Husby's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Viral Infections and Immunology Research (4 papers). Anders Husby is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Viral Infections and Immunology Research (4 papers). Anders Husby collaborates with scholars based in Denmark, Norway and United States. Anders Husby's co-authors include Jan Wohlfahrt, Mads Melbye, Anders Hviid, Jørgen Vinsløv Hansen, Henrik Toft Sørensen, Reimar W. Thomsen, Lars Køber, Christian Torp‐Pedersen, Morten Madsen and Morten Andersen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anders Husby

17 papers receiving 597 citations

Hit Papers

SARS-CoV-2 vaccination and myocarditis or myopericarditis... 2021 2026 2022 2024 2021 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Husby Denmark 12 273 191 130 117 76 18 609
Roni Baruch Israel 12 493 1.8× 85 0.4× 161 1.2× 142 1.2× 58 0.8× 27 924
Marie-Joëlle Jabagi France 12 246 0.9× 86 0.5× 38 0.3× 115 1.0× 24 0.3× 23 417
Vladimir Vuković Serbia 14 124 0.5× 41 0.2× 107 0.8× 62 0.5× 88 1.2× 53 638
Chong Boon Teo Singapore 12 361 1.3× 24 0.1× 234 1.8× 125 1.1× 43 0.6× 26 780
Florian Kälble Germany 13 252 0.9× 33 0.2× 36 0.3× 69 0.6× 40 0.5× 43 511
Wei Xue United States 10 125 0.5× 28 0.1× 74 0.6× 96 0.8× 88 1.2× 52 481
William R. Mulley Australia 17 129 0.5× 21 0.1× 64 0.5× 260 2.2× 46 0.6× 67 891
A Rees United Kingdom 11 65 0.2× 50 0.3× 63 0.5× 150 1.3× 51 0.7× 16 669
Hugo Perazzo Brazil 16 143 0.5× 66 0.3× 24 0.2× 112 1.0× 61 0.8× 60 1.1k
Yanqiu Wei China 11 293 1.1× 20 0.1× 111 0.9× 54 0.5× 93 1.2× 22 667

Countries citing papers authored by Anders Husby

Since Specialization
Citations

This map shows the geographic impact of Anders Husby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Husby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Husby more than expected).

Fields of papers citing papers by Anders Husby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Husby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Husby. The network helps show where Anders Husby may publish in the future.

Co-authorship network of co-authors of Anders Husby

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Husby. A scholar is included among the top collaborators of Anders Husby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Husby. Anders Husby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hviid, Anders, Nicklas Pihlström, Nina Gunnes, et al.. (2024). Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study. European Heart Journal. 45(15). 1327–1335. 12 indexed citations
2.
Husby, Anders, Hanne Løvdal Gulseth, Petteri Hovi, et al.. (2023). Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study. SHILAP Revista de lepidopterología. 2(1). e000373–e000373. 20 indexed citations
3.
Husby, Anders, Jan Wohlfahrt, & Mads Melbye. (2023). Gestational age at birth and cognitive outcomes in adolescence: population based full sibling cohort study. BMJ. 380. e072779–e072779. 14 indexed citations
5.
Karlstad, Øystein, Petteri Hovi, Anders Husby, et al.. (2022). SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents. JAMA Cardiology. 7(6). 600–600. 127 indexed citations breakdown →
6.
Husby, Anders, Jan Wohlfahrt, & Mads Melbye. (2022). Pregnancy duration and ovarian cancer risk: A 50‐year nationwide cohort study. International Journal of Cancer. 151(10). 1717–1725. 9 indexed citations
7.
Husby, Anders, Anton Pottegård, & Anders Hviid. (2021). Association between inhaled corticosteroid use and COVID ‐19 outcomes. Pharmacoepidemiology and Drug Safety. 30(11). 1486–1492. 4 indexed citations
8.
Husby, Anders, Jørgen Vinsløv Hansen, Emil Loldrup Fosbøl, et al.. (2021). SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. 375. e068665–e068665. 163 indexed citations breakdown →
9.
Pottegård, Anton, Kasper Bruun Kristensen, Mette Reilev, et al.. (2020). <p>Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort</p>. Clinical Epidemiology. Volume 12. 875–881. 35 indexed citations
10.
Christiansen, Christian Fynbo, Anton Pottegård, Uffe Heide‐Jørgensen, et al.. (2020). SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis. Thorax. 76(4). 370–379. 12 indexed citations
11.
Husby, Anders, Jan Wohlfahrt, & Mads Melbye. (2019). Vasectomy and Prostate Cancer Risk: A 38-Year Nationwide Cohort Study. JNCI Journal of the National Cancer Institute. 112(1). 71–77. 19 indexed citations
12.
Husby, Anders, Jan Wohlfahrt, & Mads Melbye. (2019). Pregnancy duration and endometrial cancer risk: nationwide cohort study. BMJ. 366. l4693–l4693. 21 indexed citations
13.
Husby, Anders, Jan Wohlfahrt, Nina Øyen, & Mads Melbye. (2018). Pregnancy duration and breast cancer risk. Nature Communications. 9(1). 4255–4255. 48 indexed citations
14.
Haavardsholm, Espen A., et al.. (2018). Spontan pneumomediastinum. Tidsskrift for Den norske legeforening. 138(11). 2 indexed citations
15.
Husby, Anders, et al.. (2017). Unplanned readmission and outpatient examination 90-days after acute appendectomy in adults. The American Journal of Surgery. 216(2). 217–221. 4 indexed citations
16.
Husby, Anders, Anu Pasanen, Johannes Waage, et al.. (2017). CDHR3 gene variation and childhood bronchiolitis. Journal of Allergy and Clinical Immunology. 140(5). 1469–1471.e7. 11 indexed citations
17.
Husby, Anders, et al.. (2014). Kommunikasjon som verktøy i klinisk hverdag. Tidsskrift for Den norske legeforening. 134(20). 1925–1926. 1 indexed citations
18.
Berg, Marianne, Stine A. Danielsen, Terje Ahlquist, et al.. (2010). DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset. PLoS ONE. 5(11). e13978–e13978. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026